Clinical Trial

A Study of the Beacon Platform for Holmium Laser Enucleation of the Prostate (HoLEP)

Recruiting
View on ClinicalTrials.gov →
Summary
This single-arm study aims to evaluate the Beacon Platform, an advancement in urological surgery. The study will assess its intraoperative and postoperative outcomes. The aim of this investigation is to establish safety and performance of the Beacon Platform.
Trial Details
NCT Number NCT07741656
Lead Sponsor Andromeda Surgical
Conditions BPH (Benign Prostatic Hyperplasia), HoLEP (Holmium Laser Enucleation of Prostate)
Enrollment 50 participants
Start Date 2025-09-26
Primary Completion 2026-12-31 (estimated)
Study Completion 2027-01-31 (estimated)
Updated on ClinicalTrials.gov 2026-08-03